ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1227 Centers for Disease Control and Prevention Html en Drowsy Driving and Risk Behaviors - 10 States and PuertoRico, 2011-2012 Anne G. Wheaton, PhD1, Ruth A. Shults, PhD2, Daniel P.
collision avoidance systems0.465129
binge drinkers0.495152
Janet B. Croft0.481501
adult respondents0.475312
binge drinking0.560862
risk behaviors0.522002
smoking status0.522224
fatal motor vehicle0.487135
state health departments0.475081
alcohol-impaired driving crashes0.546874
National Center0.46328
Daniel P. Chapman0.482915
response rate0.470162
insufficient sleep0.492125
Unintentional Injury Prevention0.469634
blood alcohol content0.51898
respondents0.519396
sleep-related crashes0.497868
self-reported smoking status0.475349
Frequent insufficient sleep0.486966
Earl S. Ford0.480362
Behavioral Risk Factor0.480301
drowsy driving0.977924
Puerto Rico0.715395
drowsy drivers0.595427
United States0.521919
drowsy driving prevalence0.629866
non-drowsy driving crashes0.533605
Ruth A. Shults0.483501
motor vehicle injury0.533622
Anne G. Wheaton0.548415
Traffic Safety Administration0.467062
highway safety countermeasures0.46541
fatal crashes0.494136
sleep disorders0.484508
random-digit–dialed telephone survey0.479021
response rates0.507927
non-binge drinkers0.484229
complex sampling design0.472121
vehicle injury prevention0.533465
median survey response0.487205
Chronic Disease Prevention0.467391
drowsy driving crashes0.81755
wear seatbelts0.500559
longer drowsy0.548712
optional sleep module0.544268
Community Preventive Services0.468516
motor vehicle crashes0.586186
CLICK HERE
9616 Centers for Disease Control and Prevention Html en Asthma - BRFSS 2008 - Child Asthma Data - Table L1 BRFSS 2008 - Child Asthma Data - Table L1
Puerto Rico0.660865
data0.356915
CI0.418695
normal approximation0.657786
values0.370138
standard error0.62778
states0.356687
Total0.357067
confidence interval0.944821
small sample size0.785087
caution0.400131
District0.356459
Notes0.362349
binomial distribution0.650666
estimates0.385103
CLICK HERE
11414 Centers for Disease Control and Prevention Html null Start your Conversation | Talk About HIV/AIDS | We Can Stop HIV One Conversation | Campaigns | Act Against AIDS Suggestions to start a conversation about HIV/AIDS with families, friends, and within Hispanic/Latino communities
CLICK HERE
11429 Centers for Disease Control and Prevention Html en Preventing Chronic Disease | Prevalence of Partially Hydrogenated Oils in US Packaged Foods, 2012 - CDC Although there is evidence that consumption of trans fat has declined in the United States, limited documentation exists on current levels of industrial trans fat in foods. We estimated the prevalence of partially hydrogenated oils in 4,340 top-selling US packaged foods. Nine percent of products in the sample contained partially hydrogenated oils; 84% of these products listed “0 grams” of trans fat per serving, potentially leading consumers to underestimate their trans fat consumption. Government efforts to eliminate partially hydrogenated oils from packaged foods will substantially reduce exposure to this known cardiovascular disease risk factor.
contain PHOs0.47533
WK Kellogg Foundation0.381192
foods0.434992
Human Services0.380851
Prev Chronic Dis0.402386
trans fat label0.655216
brand-name products0.381413
New York City0.446662
commonly consumed food0.406689
Packaged Foods0.405098
baked goods0.398345
National Salt Reduction0.472367
product trans0.445945
Gail P. Goldstein0.381516
food category0.435809
cardiovascular disease risk0.392636
NSRI food categories0.433605
Stars Licensing Company0.389441
NSRI Packaged Food0.527901
potentially leading consumers0.39231
Packaged Food Database0.500014
NSRI database0.41268
food service establishments0.394447
food categories0.507119
trans fat consumption0.678713
trans fat content0.575353
dietary trans0.497586
industrial trans0.70014
trans0.719178
Initiative food category0.399805
seasoned processed potatoes0.470228
United States0.40579
ingredient information0.499358
main dietary source0.394657
products0.624588
Comparable PHO-free products0.410819
Salt Reduction Initiative0.468929
PHOs0.724807
ingredient data0.400864
cardiovascular disease0.400686
FDA research findings0.389426
consumers preparing foods0.388002
risk factor0.400549
York City Department0.446648
trans fat intake0.551021
fat label data0.482948
Public Health Service0.383421
partially hydrogenated oils0.90628
CLICK HERE
11562 Centers for Disease Control and Prevention Html en Communication Resources | Ebola Hemorrhagic Fever null
Ebola Virus Infection0.614313
Interim U.S. Guidance0.378747
Ebola Questions0.576958
Africa Ebola Outbreak0.717099
Ebola Factsheet0.532906
Virus Ecology0.368057
Confirmed Ebola Patients0.595062
Outbreak Summaries0.378506
Previous Outbreak Updates0.403495
Interfacility Transport Guidance0.37588
Potential Ebola Virus0.627924
Sierra Leone Vaccine0.38221
Outbreak Communication Resources0.497716
Ebola Treatment Centers0.603453
Outbreak Preparedness0.382672
Ebola Patients0.598439
Emergency Department Guidance0.374136
Disinfecting Hospital Guidance0.374045
Ebola Epidemic0.590488
Ebola Assessment Hospitals0.573659
Virus Exposure Influenza0.38088
Ebola Diagnosed0.568519
Ebola Outbreaks0.535426
Ebola PPE0.577313
Current Ebola Treatment0.577738
Sierra Leone0.400039
Search Form Controls0.409109
Outbreak Cases0.385752
Patient Handoff SOP0.385497
All-Purpose Ebola Materials0.554416
Confirmed Ebola Virus0.60384
West Africa Outbreak0.427537
Ebola Hemorrhagic Fever0.616304
Ebola Virus Disease0.765512
Suspected Ebola Patients0.574013
Personal Protective Equipment0.386394
Ebola Survivors Questions0.590193
Communication Resources Guinea0.371132
Outbreak Distribution Map0.402247
Healthcare Settings Guidance0.383873
Handling Untreated Sewage0.384279
Ebola Transmission0.54779
West Africa Ebola0.679539
Ebola Virus Exposure0.627283
Ebola Response Planning0.58658
Ebola Virus0.91375
Ebola Outbreak Communication0.71655
Congo Outbreak0.378349
CLICK HERE
11639 Centers for Disease Control and Prevention Html en Men Living with Diagnosed HIV Who Have Sex with Men:Progress Along the Continuum of HIV Care - United States,2010 Sonia Singh, PhD1, Heather Bradley, PhD1, Xiaohong Hu, MS1, Jacek Skarbinski, MD1, H. Irene Hall, PhD1, Amy Lansky, PhD1 (Author affiliations at end of text).
National HIV/AIDS Strategy0.428978
new HIV infections0.482691
data0.406237
United States population0.369126
black/african american msm0.955048
Hispanic/Latino MSM0.489386
health outcomes0.431572
older MSM0.521598
HIV-related health disparities0.424346
viral suppression0.695973
Health care providers0.377775
Diagnosed HIV0.429072
viral suppression §§0.387893
H. Irene Hall0.367958
lowest percentage0.420578
ART prescription0.460812
persons0.386858
lower levels0.362294
undetectable viral load0.381014
HIV transmission categories0.427628
health care settings0.376754
human immunodeficiency virus0.365699
white MSM0.598051
recent viral load0.366851
care0.513991
Medical Monitoring Project0.362633
Puerto Rico0.438219
United States0.597808
HIV-negative MSM0.472225
MSM access0.474129
National HIV Surveillance0.432144
HIV Care Continuum0.471651
MSM account0.471261
highest percentage0.365441
Sonia Singh0.368226
unknown HIV status0.413515
HIV Behavioral Surveillance0.463193
HIV prevention efforts0.41469
consistent viral suppression0.379446
lowest level0.390431
HIV incidence0.390124
younger msm0.52255
National HIV Behavioral0.464932
medical care0.376
routine HIV screening0.414152
HIV0.775392
HIV testing0.409633
young MSM0.47364
CLICK HERE
12720 Centers for Disease Control and Prevention Video null Influenza El anuncio de servicio público de 60 segundos presenta a un médico experto explicando la gravedad de la influenza y la importancia de la vacuna anual contra la influenza para todas las personas de 6 meses de edad en adelante. También especifica cuáles son las personas de alto riesgo para quienes la vacunación es especialmente importante y señala que las tasas de vacunación de los hispanos han sido históricamente inferiores. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://www.cdc.gov/cdctv/FluEsp60_02/
CLICK HERE
12899 Centers for Disease Control and Prevention Html en Infant and Maternal Characteristics in Neonatal AbstinenceSyndrome - Selected Hospitals in Florida, 2010-2011 Jennifer N. Lind, PharmD1,2,3, Emily E. Petersen, MD1,3,4, Philip A.
NAS0.935972
Florida hospitals0.49785
important public health0.47295
NAS cases0.619517
death certificate data0.470353
mean NICU length0.469846
drug addiction0.515212
infant death0.475129
NAS surveillance0.630089
Defects Surveillance Program0.491435
NAS treatment0.609916
Birth Defects Surveillance0.49488
NAS scoring tools0.599746
possible NAS0.652258
infant death certificates0.475048
intensive care unit0.513765
Florida Department0.47137
administrative data0.568262
maternal medical records0.473953
NAS mothers0.606652
public health0.509085
drug addiction counseling0.504097
unique infants0.54397
inpatient discharge data0.53716
South Florida Birth0.510465
infants0.798824
NAS prevention0.575484
hospital inpatient discharge0.565971
drug addiction rehabilitation0.500837
administrative data selection0.473067
inpatient pharmacy data0.474125
Florida Birth Defects0.509432
breast milk0.48175
2-year period0.560889
drug treatment programs0.505413
Jennifer N. Lind0.508993
drug abuse treatment0.46933
Chronic Disease Prevention0.484372
Urine toxicology screens0.501859
pharmacy data0.490804
medical record0.481903
NAS births0.602939
supervised drug treatment0.504773
substance abuse treatment0.499555
NAS score0.664133
medical records0.570063
recent maternal drug0.468015
CLICK HERE
14384 Centers for Disease Control and Prevention Html en Opioid Prescriptions Among Women of Reproductive AgeEnrolled in Medicaid - New York, 2008-2013 | MMWR The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).
opioid ingredient0.438599
York’s Medicaid0.300494
York State Department0.310525
opioid component0.396319
statistics birth records0.284071
NYS Medicaid formulary0.315308
primary diagnosis code0.341646
reproductive-aged women0.385864
Medicaid0.43261
opioid pain0.456122
lower proportion0.292694
Medicaid program0.313493
New York results0.287004
opioid prescription experience0.4102
York State Medicaid0.311073
New York State0.445668
pregnancy0.288398
opioid drugs0.416299
prenatal opioid prescriptions0.467735
female Medicaid recipients0.310389
opioid pain medication0.447342
ICD-9 primary diagnosis0.293337
public health practice0.283857
prenatal period0.469411
opioid prescribing0.384861
indication0.369525
women0.767994
proportion0.362763
United States0.309733
opioid prescription0.469725
opioid drug prescriptions0.48631
live birth0.805997
average proportion0.350284
average prenatal period0.286135
opioid prescriptions0.974069
medicaid services0.305169
New York0.862948
nonprescribed contraceptive methods0.299571
reproductive age0.572704
Current Procedural Terminology0.339932
opioid exposure0.434812
enrolled women0.308321
birth defects0.28961
ICD-9 code0.304459
opioid medications0.393904
lowest opioid prescription0.418296
neonatal abstinence syndrome0.355463
Medicaid drug claims0.317246
opioid pain medications0.447344
CLICK HERE
14632 Centers for Disease Control and Prevention Html en Build Your Own Zika Prevention Kit Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention.
sunscreen0.300376
condoms0.272754
skin0.238007
Zika virus0.7535
right way0.439979
EPA-registered insect repellent0.920906
standing water0.448827
pregnant women0.511395
permethrin0.331145
mosquitoes0.457028
package0.245764
breastfeeding women0.442598
night0.247738
insect repellents0.518525
bites0.251606
room0.248038
mosquito0.238784
sexually transmitted diseases0.725289
insect repellent0.949123
bed net0.477255
water treatment tabs0.748581
directions0.387028
Zika Prevention Kit0.806729
clothing0.23678
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.